The mark consists of the stylized word "XCOPRI" in purple upper case letters. The letter "O" contains a red circular design divided by a triangular ray, which extends past the letter "O". The remaining color white represents background and is not a feature of the mark.
Mark For: XCOPRI® trademark registration is intended to cover the categories of
>The colors purple and red are claimed as a feature of the mark. The mark consists of the stylized word "XCOPRI" in purple upper case letters. The letter "O" contains a red circular design divided by a triangular ray, which extends past the letter "O". The remaining color white represents background and is not a feature of the mark.
Research | OneLook Acronym Finder |
Serial Number | 88484180 |
Registration Number | 6125911 |
Mark Literal Elements | XCOPRI |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-01-06 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | Yes |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Diane J. Mason |
Law Office Assigned | N50 |
Employee Name | SHERMAN, SAMANTHA LEIG |
2019-06-21 | Application Filed |
2020-01-02 | Location: TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED |
2020-01-02 | Status: Live/Pending |
2020-01-02 | Transaction Date |
2020-01-06 | Location: PUBLICATION AND ISSUE SECTION |
2020-02-11 | Published |
2020-02-11 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
2020-08-11 | Trademark Registered |
Party: | SK BIOPHARMACEUTICALS CO., LTD. |
Address | 221, Pangyoyeok-ro, Bundang-gu Seongnam-si KOREA, REPUBLIC OF 13494 |
Legal Entity Type | Corporation |
Legal Entity State | KOREA, REPUBLIC OF |
Drawing | JPEG | 2019-06-21 |
TEAS RF New Application | MULTI | 2019-06-21 |
Design Search Code Corr Project | APPLICATION/XML | 2019-07-03 |
Notation to File | XML | 2019-09-16 |
Suspension Letter | XML | 2019-09-16 |
XSearch Search Summary | APPLICATION/XML | 2019-09-16 |
TEAS Response to Suspension Inquiry | XML | 2019-11-27 |
Amendment and Mail Process Complete | MULTI | 2019-12-24 |
Amendment to Delete or Correct Basis | MULTI | 2020-01-03 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-01-03 |
Notice of Publication | XML | 2020-01-22 |
Notification Of Notice of Publication | XML | 2020-01-22 |
OG Publication Confirmation | APPLICATION/XML | 2020-02-11 |
26.05.28 | Miscellaneous designs with overall triangular shape; Triangular shape (miscellaneous overall shape) |
260128 | Circles with irregular circumferences; Miscellaneous circular designs with an irregular circumference |
260528 | Miscellaneous designs with overall triangular shape; Triangular shape (miscellaneous overall shape) |
IC 005. US 006 018 044 046 051 052. G & S: Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets |
CC0000 | The colors purple and red are claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
PUBLISHED FOR OPPOSITION | 2020-02-11 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-02-11 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-01-22 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-02 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-23 | 70633 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-23 | 70633 |
ASSIGNED TO LIE | 2019-12-11 | 70633 |
ASSIGNED TO LIE | 2019-12-06 | 74221 |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2019-11-27 | |
ASSIGNED TO EXAMINER | 2019-10-07 | 93419 |
SUSPENSION LETTER WRITTEN | 2019-09-16 | 93421 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-09-16 | 6332 |
LETTER OF SUSPENSION E-MAILED | 2019-09-16 | 6332 |
ASSIGNED TO EXAMINER | 2019-09-12 | 93421 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2019-07-03 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-07-02 | |
NEW APPLICATION ENTERED IN TRAM | 2019-06-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.